# Lakefront Biotherapeutics (GLPGF)

> Healthcare · BE · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GLPGF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 1.13B | € 325.83M | € 31.86M | € 12.10M | € 3.23B |
| 2024 | € 285.58M | € 76.75M | € -103.01M | € 11.72M | € 2.90B |
| 2023 | € 254.39M | € 224.65M | € -355.27M | € 9.60M | € 2.80B |
| 2022 | € 551.76M | € -238.05M | € -1.91B | € 21.90M | € 2.53B |
| 2021 | € 578.16M | € -123.10M | € 44.61M | € 26.86M | € 2.64B |
| 2020 | € 598.39M | € -382.32M | € 413.01M | € 29.44M | € 2.67B |
| 2019 | € 1.05B | € 187.04M | € -694.06M | € 25.38M | € 2.88B |
| 2018 | € 365.34M | € -37.01M | € -200.33M | € 0 | € 1.21B |
| 2017 | € 163.19M | € -148.58M | € -189.51M | € 9.0K | € 1.01B |
| 2016 | € 168.56M | € 70.29M | € 302.08M | € 63.0K | € 758.70M |
| 2015 | € 52.05M | € -155.79M | € -156.41M | € 115.0K | € 365.00M |
| 2014 | € 104.14M | € -49.16M | € 51.04M | € 167.0K | € 206.14M |
| 2013 | € 127.15M | € -22.13M | € -13.35M | € 393.0K | € 167.14M |
| 2012 | € 35.53M | € 5.19M | € -37.52M | € 405.0K | € 118.45M |
| 2011 | N/A | N/A | N/A | € 876.0K | € 118.38M |
| 2010 | N/A | N/A | N/A | € 1.25M | € 148.51M |
| 2009 | N/A | N/A | N/A | € 1.48M | € 108.88M |
| 2008 | N/A | N/A | N/A | € 1.70M | € 84.32M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.05 |
| Current Ratio | 20.15 |

## Other views

- [Metrics](https://sponda.capital/en/GLPGF.md)
- [Charts](https://sponda.capital/en/GLPGF/charts.md)
- [Compare](https://sponda.capital/en/GLPGF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.